Ladenburg Thalmann Financial Services’s Cytosorbents Corp CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$7K Sell
1,800
-385
-18% -$1.68K ﹤0.01% 4630
2019
Q3
$11K Buy
2,185
+1,385
+173% +$8.06K ﹤0.01% 4339
2019
Q2
$5K Hold
800
﹤0.01% 4702
2019
Q1
$7K Sell
800
-1,270
-61% -$9.89K ﹤0.01% 4518
2018
Q4
$17K Hold
2,070
﹤0.01% 3957
2018
Q3
$27K Hold
2,070
﹤0.01% 3710
2018
Q2
$14K Hold
2,070
﹤0.01% 4043
2018
Q1
$14K Buy
2,070
+870
+73% +$6.58K ﹤0.01% 4043
2017
Q4
$8K Sell
1,200
-37,900
-97% -$241K ﹤0.01% 4298
2017
Q3
$242K Sell
39,100
-500
-1% -$2.55K ﹤0.01% 1960
2017
Q2
$170K Sell
39,600
-2,569
-6% -$11.3K ﹤0.01% 2134
2017
Q1
$190K Sell
42,169
-1,150
-3% -$6.43K ﹤0.01% 1950
2016
Q4
$236K Sell
43,319
-2,100
-5% -$11.5K ﹤0.01% 1698
2016
Q3
$291K Buy
45,419
+21,350
+89% +$111K ﹤0.01% 1500
2016
Q2
$110K Buy
24,069
+469
+2% +$2.04K ﹤0.01% 2087
2016
Q1
$93K Buy
23,600
+4,419
+23% +$19.2K ﹤0.01% 2118
2015
Q4
$107K Buy
+19,181
New +$131K ﹤0.01% 2006

Other funds holding CTSO

Ladenburg Thalmann Financial Services's CTSO Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services reduced its Cytosorbents Corp (CTSO) stake by 18% in Q4 2019, selling an estimated $1.68K and leaving 1,800 shares worth $7K. The position accounts for ﹤0.01% of the portfolio, ranked #4630.

Ladenburg Thalmann Financial Services first reported a position in CTSO in Q4 2015 and has held it in 17 quarters since. The position peaked at $291K in Q3 2016. 72 funds tracked by Wall St. Rank hold CTSO as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 1,800 shares of Cytosorbents Corp worth $7K as of Q4 2019.
  • Ladenburg Thalmann Financial Services sold 385 Cytosorbents Corp shares in Q4 2019, an estimated $1.68K.
  • Cytosorbents Corp made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4630 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Cytosorbents Corp in Q4 2015 and has held it in 17 quarters since.
  • Ladenburg Thalmann Financial Services's Cytosorbents Corp position peaked at $291K in Q3 2016.
  • 72 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.